Neurological disorders in pregnancy

Current Women's Health Reviews

Volumn 7, Issue 2, 2011, Pages 217-225

  Shehata, Hassan A ^a   Gupta, Sahana ^b  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Bell's palsy; Benign intracranial hypertension; Cerebrovascular; Epilepsy; Headache; Multiple sclerosis; Myasthenia gravis; Neurological; Pregnancy

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; CALCIUM CHANNEL BLOCKING AGENT; CAMOTRIGIN; CARBAMAZEPINE; CODEINE; ETIRACETAM; FOLIC ACID; GABAPENTIN; GLATIRAMER; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; LAMOTRIGINE; LORAZEPAM; NAPROXEN; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; STEROID; SUMATRIPTAN; THIAMINE; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ALCOHOLISM; ANESTHESIA; ARTICLE; BELL PALSY; BRAIN ISCHEMIA; BRAIN PSEUDOTUMOR; BREAST FEEDING; CARPAL TUNNEL SYNDROME; CEREBROVASCULAR DISEASE; CESAREAN SECTION; CLEFT FACE; CLEFT PALATE; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIAL SINUS; DRUG BLOOD LEVEL; EPILEPSY; EPILEPTIC STATE; HEADACHE; HUMAN; HYPOSPADIAS; LIP MALFORMATION; MATERNAL HYPERTENSION; MIGRAINE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; NONHUMAN; OBSTETRIC ANALGESIA; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REGIONAL ANESTHESIA; SMALL FOR DATE INFANT; SUBARACHNOID HEMORRHAGE; TERATOGENICITY; THIAMINE DEFICIENCY; VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION;

EID: 79955731528     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340411795445848     Document Type: Article

References (107)

1. Bardy A. Epilepsy and pregnancy: a prospective study of 154 pregnancies in epileptic women. Finland: University of Helsinki;1982.
2. Kaaja E. Kaaja R, Hiilesmaa. Major malformations in the off spring of women with epilepsy. Neurology 2003; 601: 575-9.
3. Report of the quality standards subcommittee of the American Academy of Neurology. Practice Parameter: management issues for women with epilepsy (summary statement). Neurology 1998; 51:944-948.
4. Sankar R. Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics. Acta Neurol Scand 2007; 116:65-71.
5. Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmentalimpact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007; 48(Suppl 5): 19-26.
6. Morrow J, Russell A, Guthrie E. Malformations risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193-8.
7. Hassan AS, Okosun Henry. Neurological disorders in pregnancy. Curr Opin Obstet Gynecol 2004; 16: 117-22.
8. Puho EH, Szunyogh M, Metneki J, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in Hungary. Cleft Palate Craniofac J 2007; 4: 194-202.
9. Arpino C, Brescianini S, Robert E, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000; 41:1436-43.
10. Canger R, Battino D, Canevini MP. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999; 40:1231-6.
11. Holmes LB, Baldwin EJ, Smith CR, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008; 70(22 Pt 2): 2152-8.
12. Mamoli D, Ratti S, Battino D. Epilepsy and pregnancy. Neurol Sci 2003; 23: 267-9.
13. Harden CL, Sethi NK. Epileptic disorders in pregnancy: an overview. Curr Opin Obstet Gynecol 2008; 20: 557-62.
14. Adab N, Kini U, Vinten J, et al. The longer term outcome ofchildren born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 1575-83.
15. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62: 28-32.
16. Fedrick J. Epilepsy and pregnancy: a report from the Oxford Record Linkage Study. BMJ 1973; 2: 442-8.
17. Betts T, Crawford P. Women and epilepsy. London, Martin Dunitz, 1998.
18. Knight RH, Rhind EG. Epilepsy and pregnancy: a study of 153pregnancies in 59 patients. Epilepsia 1975; 16: 99-110.
19. Hvas CL, Henriksen TB, Ostergaard JR, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. BJOG 2000; 107: 896-902.
20. Viinikainen K, Heinonen S, Eriksson K, Kalviainan R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.Epilepsia 2006; 47: 186-92.
21. Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004; 190: 371-9.
22. Vajda FJ, Hitchcock A. Graham J, et al. Seizure control in antiepileptic treated pregnancy. Epilepsia 2008; 49(l): 172-6.
23. Berry RJ, Li Z, Erickson JO, et al. Prevention of neural-tubedefects with folic acid in China. New Eng J Med 1999; 341: 1485-90.
24. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131.
25. Czeieel AE, Dudas I. Prevention of the first occurrence of neural rube defects by periconceptual vitamin supplementation. N Engl JMed 1992; 327: 1832-5.
26. Craig J, Morrison P, Morrow J. Failure of periconceptual folic acid to prevent a neural rube defect in the offspring of a mother taking sodium valproate. Seizure 1999; 8: 253-4.
27. Rosenberg IH. Folic acid and neural-tube defects: time for action? N Engl J Med 1992; 327(26): 1875-7.
28. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 2003;44(Suppl 3): 33-40. Erratum; 2003; 44: 1465.
29. Yerby MS. Management issues for women with epilepsy. Neural rube defects and folic acid supplementation. Neurology 2003; 61(6Suppl 2): 523-6.
30. Rothenberg SB, Da Costa M, Sequeira MS. Production of antibodies to folate receptors in women with a pregnancy complicated by a neural tube defect. N Eng J Med 350; 2: 134-42.
31. Botto Lisi et al. 2005 International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2007; 334: 433-4.
32. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001; (3):CD001056.
33. Beach RL, Kaplan PW. Seizures in pregnancy: diagnosis and management. Intern Rev Neuro Biol 2008; 83: 259-271.
34. Scharff L, Marcus DA, Turk DC. Headache during pregnancy and intrapartum: a prospective study. Headache 1997; 37: 203-10.
35. Von Wald T, Walling AD. Headache during pregnancy. Obstet Gynecol Survey 2002; 57: 179-85.
36. Silberstein SD. Headache and female hormones: what you need to know. Curr Opin Neurol 2001; 14: 323-33.
37. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 1997; 17: 756-69.
38. Maggioni F, Alessi C, Maggino T, Zanchin G. Headaches during pregnancy. Cephalalgia 1997; 17(7): 765-9.
39. Martin RS, Foley MR. Approach to pregnant patient with headache. Clinical Obstetrics & Gynaecology 2005; 48: 2-11.
40. Sances G, Granella F, Nappi RE. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23: 197-205.
41. Silberstein SD. Migraine and pregnancy. Neurol Clin 1997; 15:209-31.
42. Marcus DA. Focus on primary care diagnosis and management of headache in women. Obstet Gynecol Surv 1999; 54: 395-402.
43. Lewis JB, Frohman EM. Diagnosis and management of headache. Obstet Gynecol Clin North Am 2001; 28: 205-24.
44. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Baltimore, MD Lippincott Williams and Wilkins,2001.
45. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002; 59: 1492-5.
46. Lesny P, Maguiness SD, Hay DM. Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: case report. Hum Reprod 1999; 14: 1953-5.
47. Corbett JJ. In: Kennard C, Eds. Idiopathic intracranial hypertension.Recent advances in clinical neurology. Edinburgh, Churchill Livingstone 1995; pp. 51-73.
48. Digre KB. Not so benign intracranial hypertension: condition needs to be diagnosed before patients develop visual symptoms. BMJ 2003; 326: 613-4.
49. Lee M, O'Brian P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 1308-11.
50. Aramsky O, Brenner T, Mizrachi R, et al. Alpha-fetoproteinsuppresses EAE. J Neuro-immunol 1982; 2: 1-7.
51. Beth A, Mueller JZ, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 2002; 186: 446-52.
52. van Walderveen MA, Tas MW, Barkhof F. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994; 44: 327-9.
53. Dahl J, Myhr KM, Daltveit AK. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005; 65:1961-3.
54. Giesser B. Pregnancy and multiple sclerosis: the current view. Mult Scler Q Rep 2001; 20: 68.
55. Hutchinson M. In: Alan J. Thompson, Chris Polman, Reinhard Hohlfeld Eds. Does pregnancy make multiple sclerosis better orworse? Multiple sclerosis: clinical challenges and controversies. London, Martin Dunitz 1997.
56. Dorotta IR, Schubert A. Multiple sclerosis and anaesthetic implication. Curr Opin Anaesthesiol 2002; 15: 365-70.
57. Crawford JS. Epidural analgesia for patients with chronic neurological disease. Anesth Analg 1983; 62: 621-2.
58. Confavreux C, Hutchison M, Hours MML. The pregnancy in multiple sclerosis group. Rate of pregnancy related relapse in multiple sclerosis. N Eng J Med 1998; 339: 285-91.
59. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast feeding. J Am Med Assoc 1988; 259: 3441-3.
60. Pijnenborg IMA, Hansen ECM, Brotmann IIAM, Oei SG, Andriessen P, Dellentijn PLD. A severe case of myasthenia gravis during pregnancy. Gynecol Obstet Invest 2000; 50: 142-3.
61. Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy.Neurology 1999; 52: 447-52.
62. Sanders DB, Howard JF. Diseases of neuromuscular transmission.In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, Eds. Neurology in clinical practice. Boston, MA: Butterworth-Heinemann; 2000. pp. 2167-85.
63. Batocchi AP, Majolini L, Evoli A. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52:447-52.
64. Barocchi AR, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52: 447-52.
65. Dick-Ms J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravisin pregnancy: report on 69 cases. Em J Obstet Gynae Reprod Biol 2002; 104(1): 21-5.
66. Giwa-Osagic OF, Newton JR, Larcher V. Obstetric performance of patients with myasthenia gravis. Int J Gynaecol Obstet 1981; 19(4):267-70.
67. Hoff JM, Daltveit AK, Gallus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 2003; 61(10): 1362-6.
68. Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34(1): 82-99.
69. Hoff JM, Dalveit AK, Gilhus NE. Arthrogryposis multiplex congenita: a rare fetal condition caused by maternal myasthenia gravis. Acta Neural Scand Suppl 2006; 183: 26-7.
70. Polizzi A, Huson SM, Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 2000; 62: 332-41.
71. Plauche WC. Myasthenia gravis. Clin Obstet Gynecol 1983; 26:592-604.
72. Donaldson JO, Penn AS, Lisak RP, et al. Anti-acetylcholinereceptor antibody in neonatal myasthenia gravis. Am J Dis Child1981; 135: 222-5.
73. Plauche WC. Myasthenia gratis in pregnancy: an update. Am JObstet Gynecol 1979; 135: 691-7.
74. Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynaecol 1991; 34: 82-99.
75. Carr SR, Gilchrist JM, Abuelo DN, Clark D. Treatment of antenatalmyasthenia gravis. Obstet Gynecol 1991; 78: 485-9.
76. Watson WJ, Katz VL, Bowes WA. Plasmapheresis during pregnancy. Obstet Gynecol 1984; 76: 451-7.
77. Kaaja R, Julkunen A, Ammala P, et al. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta ObstetGynecol Scand 1993; 72: 63-6.
78. Osserman KE, Kornfeld P, Cohen E. Studies in myasthenia gravis. AMA Arch Intern Med 1958; 102: 72-81.
79. Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol1975; 84: 433-442.
80. Roob G, Fazekas F, Hartung HP. Peripheral facial palsy: etiology,diagnosis and treatment. Eur Neurol 1999; 41: 3-9.
81. Shmorgun D, Chan WS, Ray JG. Association between Bell's palsyin pregnancy and pre-eclampsia. Q J Med 2002; 95: 359-362.
82. Murakami S, Mizobuchi M, Narashiro Y. Bell's palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Intern Med 1996; 124: 27-30.
83. Falco NA, Eriksson E. Idiopathic facial palsy in pregnancy and the puerperium. Surg Gynecol Obstet 1989; 169: 337-40.
84. Gillman GS, Schaitkinrim, May M, Klein SR. Bell's palsy inpregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126: 26-30.
85. Sax TW, Rosenbaum RB. Neuromuscular disorders in pregnancy. Muscle Nerve 2006; 34: 559-71.
86. Atkin P. Diagnosis and management of Bell's palsy. The Practitioner 2002; 24: 36-42.
87. Ramsey MJ, DerSimonian R, Holtel MR, Burgess LP.Corticosteroid treatment for idiopathic facial nerve paralysis: ameta-analysis. Laryngoscope 2000; 110: 335-41.
88. Mabie WE. Peripheral neuropathies during pregnancy. Clin ObstetGynaecol 2005; 48: 57-66.
89. Ekman-Ordeberg G, Salgeback S, Ordeberg G. Carpal tunnel syndrome in pregnancy. A prospective study. Acta Obstet Gynecol Scand 987; 66: 233-5.
90. Wand JS. Carpal tunnel syndrome in pregnancy and lactation. J Band Surg 1990; 15B: 93-5.
91. Turgut F, Cetinşahinahin M, Turgut M, Bölükbaşi O. Themanagement of carpal tunnel syndrome in pregnancy. J ClinNeurosci 2001; 8: 332-854.
92. Shashar R, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium: a study in the publichospitals of Ile de France. Stroke 1995; 26: 930-6.
93. Bousser MG. Cerebral venous thrombosis: nothing, heparin, orlocal thrombolysis? Stroke 1 1999; 30: 481-3.
94. Feske SK. Stroke in pregnancy. Semin Neurol 2007; 27: 442-52
95. Tomlinson MW. In: Dildy GA, Belfort MA, Saade GR, Eds.Cerebrovascular accidents. Critical Care Obstetrics. Malden, MABlackwell Science 2004, 240-51.
96. de Brujin SFTM, Stam J. Randomized, placebo-controlled trail of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484-8.
97. Cantu C, Baringgarrementeria F. Cerebral venous thrombosis associated with pregnancy and the puerperium: review of 67 cases. Strokes 1993; 24: 1880-4.
98. Simioni P, Prandoni P. The risk of recurrent venous thromboembolicin patients with an Arg 506-Gln mutation in the gene forfactor V (factor V Leiden). N Engl J Med 1997; 336: 339-403.
99. Mutzel W, Speck U. Pharmacokinetics and biotransformation of iohexol in the rat and the dog. Acta Radiol Suppl 1980; 362: 87-92.
100. Adams HP, Adams RJ, Brott T. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056-83.
101. Furlan AJ, Higashida R, Wechsler L. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomised controlled trial. JAMA 1999; 282: 2003-11.
102. Sloan MA, Stern BJ. Cerebrovascular disease in pregnancy. Curr Opin Neurol 2003; 5: 391-407.
103. Lamy C, Hamon JB, Coste J, Mas JL. The French Study Group on Stroke in Pregnancy. Neurology 2000; 55: 269-74.
104. Waddy S, Stern BJ. Cerebrovascular disease in pregnancy. Curr Treat Options Cardiovasc Med 2003; 5: 241-9.
105. Dias M, Sekar LN. Intracranial haemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990; 27: 855-66.
106. Ng J, Kitchen N. Neurosurgery and pregnancy. J Neurol Neurosurg Psychiatry 2008; 79: 745-52.
107. Kuczkowski KM. Labor analgesia for the parturient with neurological disease: what the obstetrician needs to know? Arch Gynecol Obstet 2006; 274: 41-6.